Role of serum vaspin in progression of type 2 diabetes: A 2-year cohort study

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Jian, Weixia ^a   Peng, Wenhui ^b   Xiao, Sumei ^c   Li, Hailing ^b   Jin, Jie ^a   Qin, Li ^a   Dong, Yan ^a   Su, Qing ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; VASPIN; GLUCOSE; GLUCOSE BLOOD LEVEL; SERINE PROTEINASE INHIBITOR; SERPINA12 PROTEIN, HUMAN;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; KIDNEY FUNCTION; LIPID METABOLISM; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK FACTOR; WAIST HIP RATIO; AGED; ANALYSIS; BLOOD; METABOLISM; PATHOLOGY; PROCEDURES; REGRESSION ANALYSIS;

ADIPONECTIN; AGED; ANTHROPOMETRY; BLOOD GLUCOSE; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; SERPINS;

EID: 84899620738     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094763     Document Type: Article

References (35)

1. Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89: 2548-2556. (Pubitemid 38766330)
2. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, et al. (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46: 459-469. (Pubitemid 36577787)
3. Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G (2002) Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 25: 971-976. (Pubitemid 41110480)
4. Matsubara M, Maruoka S, Katayose S (2002) Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 87: 2764-2769. (Pubitemid 34655342)
5. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, et al. (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet 361: 226-228. (Pubitemid 36126226)
6. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, et al. (2002) Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360: 57-58. (Pubitemid 34756495)
7. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocytesecreted protein Acrp30 enhances hepatic insulin action. Nat Med 7: 947-953. (Pubitemid 32756433)
8. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, et al. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98: 2005-2010. (Pubitemid 32165613)
9. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, et al. (2001) The fatderived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946. (Pubitemid 32756432)
10. Hida K, Wada J, Eguchi J, Zhang H, Baba M, et al. (2005) Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci U S A 102: 10610-10615. (Pubitemid 41061602)
11. Kloting N, Kovacs P, Kern M, Heiker JT, Fasshauer M, et al. (2011) Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. Diabetologia 54: 1819-1823.
12. Kloting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, et al. (2006) Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun 339: 430-436. (Pubitemid 41697566)
13. Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, et al. (2008) Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance. Diabetes 57: 1501-1507.
14. Aktas B, Yilmaz Y, Eren F, Yonal O, Kurt R, et al. (2011) Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease. Metabolism 60: 544-549.
15. Cakal E, Ustun Y, Engin-Ustun Y, Ozkaya M, Kilinc M (2011) Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome. Gynecol Endocrinol 27: 491-495.
16. Choi SH, Kwak SH, Lee Y, Moon MK, Lim S, et al. (2011) Plasma vaspin concentrations are elevated in metabolic syndrome in men and are correlated with coronary atherosclerosis in women. Clin Endocrinol (Oxf) 75: 628-635.
17. Aust G, Richter O, Rohm S, Kerner C, Hauss J, et al. (2009) Vaspin serum concentrations in patients with carotid stenosis. Atherosclerosis 204: 262-266.
18. Grimaldi A, Heurtier A (1999) Diagnostic criteria for type 2 diabetes. Rev Prat 49: 16-21.
19. Mills GW, Avery PJ, McCarthy MI, Hattersley AT, Levy JC, et al. (2004) Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to type 2 diabetes. Diabetologia 47: 732-738. (Pubitemid 38658376)
20. Ling Li H, Hui Peng W, Tao Cui S, Lei H, Dong Wei Y, et al. (2011) Vaspin plasma concentrations and mRNA expressions in patients with stable and unstable angina pectoris. Clin Chem Lab Med 49: 1547-1554.
21. Teshigawara S, Wada J, Hida K, Nakatsuka A, Eguchi J, et al. (2012) Serum vaspin concentrations are closely related to insulin resistance, and rs77060950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population. J Clin Endocrinol Metab 97: E1202-1207.
22. Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, et al. (2005) Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 280: 18073-18080. (Pubitemid 41389052)
23. Seeger J, Ziegelmeier M, Bachmann A, Lossner U, Kratzsch J, et al. (2008) Serum levels of the adipokine vaspin in relation to metabolic and renal parameters. J Clin Endocrinol Metab 93: 247-251.
24. Youn BS, Kloting N, Kratzsch J, Lee N, Park JW, et al. (2008) Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 57: 372-377.
25. Korner A, Neef M, Friebe D, Erbs S, Kratzsch J, et al. (2011) Vaspin is related to gender, puberty and deteriorating insulin sensitivity in children. Int J Obes (Lond) 35: 578-586.
26. Auguet T, Quintero Y, Riesco D, Morancho B, Terra X, et al. (2011) New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet 12: 60.
27. von Loeffelholz C, Mohlig M, Arafat AM, Isken F, Spranger J, et al. (2010) Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans. Eur J Endocrinol 162: 507-513.
28. Giomisi A, Kourtis A, Toulis KA, Anastasilakis AD, Makedou KG, et al. (2011) Serum vaspin levels in normal pregnancy in comparison with non-pregnant women. Eur J Endocrinol 164: 579-583.
29. Genc H, Dogru T, Tapan S, Kara M, Ercin CN, et al. (2011) Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis. Scand J Gastroenterol 46: 1355-1361.
30. Wada J (2008) Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 17: 327-333. (Pubitemid 351578185)
31. Shaker OG, Sadik NA (2013) Vaspin gene in rat adipose tissue: relation to obesity-induced insulin resistance. Mol Cell Biochem 373: 229-239.
32. Gulcelik NE, Karakaya J, Gedik A, Usman A, Gurlek A (2009) Serum vaspin levels in type 2 diabetic women in relation to microvascular complications. Eur J Endocrinol 160: 65-70.
33. Fagerberg B, Kellis D, Bergstrom G, Behre CJ (2011) Adiponectin in relation to insulin sensitivity and insulin secretion in the development of type 2 diabetes: a prospective study in 64-year-old women. J Intern Med 269: 636-643
34. Li Y, Yatsuya H, Iso H, Toyoshima H, Tamakoshi K (2012) Inverse relationship of serum adiponectin concentration with type 2 diabetes mellitus incidence in middle-aged Japanese workers: six-year follow-up. Diabetes Metab Res Rev 28: 349-356.
35. Suleymanoglu S, Tascilar E, Pirgon O, Tapan S, Meral C, et al. (2009) Vaspin and its correlation with insulin sensitivity indices in obese children. Diabetes Res Clin Pract 84: 325-328.